Primoris (PRIM) director Harpreet Saluja receives $37,500 stock grant

Rhea-AI Filing Summary

Saluja Harpreet reported acquisition or exercise transactions in this Form 4 filing.

Primoris Services Corp director Harpreet Saluja received a restricted stock award of 268 shares of common stock. The grant has a stated value of $37,500 under the company’s non-employee director compensation program. The price per share was based on the average closing price during March 2026, and the shares cannot be sold for twelve months from the grant date. Following this award, Saluja directly holds 1,363 Primoris shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Saluja Harpreet

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	268	$0.00	--

Holdings After Transaction: Common Stock — 1,363 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Restricted stock grant: 268 shares Grant value: $37,500 Holdings after grant: 1,363 shares +2 more

5 metrics

Restricted stock grant 268 shares Common stock award on April 30, 2026

Grant value $37,500 Non-employee director compensation program

Holdings after grant 1,363 shares Director’s direct Primoris holdings post-transaction

Sale restriction period 12 months Shares cannot be sold for twelve months from grant date

Pricing method Average March 2026 close Grant price per share based on average closing price in March 2026

Key Terms

restricted stock, non-employee director compensation program, average closing price, grant of 268 shares, +1 more

5 terms

restricted stock financial

"provides for the issuance of restricted stock with a value of $37,500"

Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

non-employee director compensation program financial

"The non-employee director compensation program adopted by the Board in May 2011 and updated July 2024"

average closing price financial

"The price per share was based on the average closing price during March 2026"

grant of 268 shares financial

"resulting in a grant of 268 shares of stock"

cannot be sold for a period of twelve months financial

"The shares of stock cannot be sold for a period of twelve months from the date of grant"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Saluja Harpreet

(Last) (First) (Middle)

C/O PRIMORIS SERVICES CORPORATION

2300 N. FIELD STREET, SUITE 1900

(Street)

DALLAS TEXAS 75201

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Primoris Services Corp [ PRIM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/30/2026		A		268	A	(1)	1,363	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The non-employee director compensation program adopted by the Board in May 2011 and updated July 2024, provides for the issuance of restricted stock with a value of $37,500. The price per share was based on the average closing price during March 2026, resulting in a grant of 268 shares of stock. The shares of stock cannot be sold for a period of twelve months from the date of grant.

	/s/ Kenneth M. Dodgen, Attorney-in-Fact	05/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Primoris (PRIM) director Harpreet Saluja report on this Form 4?

Director Harpreet Saluja reported receiving 268 shares of Primoris common stock as a restricted stock award. The grant is part of the non-employee director compensation program and increases Saluja’s direct holdings to 1,363 shares after the transaction.

What is the value of the restricted stock granted to Primoris (PRIM) director Harpreet Saluja?

The restricted stock award to director Harpreet Saluja has a stated value of $37,500. This value comes from Primoris’s non-employee director compensation program, which specifies that restricted stock grants to directors are sized to reflect that dollar amount.

How many Primoris (PRIM) shares did Harpreet Saluja hold after the restricted stock award?

After receiving the 268 restricted shares, director Harpreet Saluja directly holds 1,363 Primoris common shares. This figure includes the newly granted award and represents Saluja’s direct ownership position as reported in the Form 4 filing.

How was the grant price determined for Harpreet Saluja’s Primoris (PRIM) restricted stock?

The grant price for Harpreet Saluja’s restricted stock was based on Primoris’s average closing share price during March 2026. Using that average, the company sized the award to deliver $37,500 in value, resulting in a grant of 268 restricted shares.

Are there any sale restrictions on the Primoris (PRIM) restricted shares granted to Harpreet Saluja?

Yes. The 268 restricted shares granted to director Harpreet Saluja cannot be sold for twelve months from the grant date. This holding requirement aligns with Primoris’s non-employee director compensation program for restricted stock awards.